Kronos Bio Presents Positive Preliminary Data from Phase 1 D

Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC

Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Boston , Massachusetts , United States , Jorge Dimartino , Miguel Villalona Calero , Sarah Connors , Kronos Bio , Kronos Bio Inc , International Conference , Linkedin , Agency Contact , Exchange Commission , City Of Hope National Medical Center , Nasdaq , Company Contact , Clinical Development , Corporate Communications , Hope National Medical , Chief Medical Officer , Executive Vice President , Medical Oncologist , Early Therapeutics , Agent Anti Tumor Activity , Heavily Pre Treated Patients , Transcriptionally Addicted Tumor , Safety Profile , Hope National Medical Center , San Mateo , Private Securities Litigation Reform Act , Quarterly Report , Vice President , Investor Relations ,